4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-020686
EVP, CFO & CBO acquired 15,486 shares (option exercise)
- EVP, CFO & CBO gave up 2,625 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Mahatme Sandesh · EVP, CFO & CBO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 1 in the form | +11,768 | $23.85 | $280,667 | 15,636 | D |
| 2019-03-19 | Exercise or conversion : show line 2 in the form | +3,511 | $13.90 | $48,803 | 19,147 | D |
| 2019-03-19 | Exercise or conversion : show line 3 in the form | +164 | $13.71 | $2,248 | 19,311 | D |
| 2019-03-19 | Exercise or conversion : show line 4 in the form | +43 | $13.71 | $590 | 19,354 | D |
| 2019-03-19 | Shares withheld for taxes : show line 5 in the form | −2,625 | $126.47 | $331,984 | 16,729 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −11,768 | $23.85 | 2022-11-05 | 11,768 | 0 | D |
| 2019-03-19 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −3,511 | $13.90 | 2025-02-27 | 3,511 | 2,625 | D |
| 2019-03-19 | Exercise or conversion : show line 8 in the form Stock option (right to buy) | −164 | $13.71 | 2026-02-28 | 164 | 3,370 | D |
| 2019-03-19 | Exercise or conversion : show line 9 in the form Stock option (right to buy) | −43 | $13.71 | 2026-02-28 | 43 | 478 | D |
Loading xslF345X03/doc4.xml…